Wall Street analysts forecast that Regeneron (REGN) will report quarterly earnings of $8.03 per share in its upcoming release, pointing to a year-over-year decline of 30.5%. It is anticipated that ...

Regeneron Pharmaceuticals is on the cusp of unveiling its Q2 2025 earnings this Friday, with expectations pinned at $8.53 per share and a revenue forecast of $3.30 billion. Analysts are eyeing a ...

John G Ullman & Associates Inc. made a hefty bet on Regeneron Pharmaceuticals, upping their stake by a whopping 94%, now ...

Regeneron Pharmaceuticals will release its second-quarter earnings next month, and analysts anticipate a double-digit profit ...

Shares of Regeneron Pharmaceuticals, Inc. REGN have lost 22.6% year to date against the industry’s growth of 0.6%. The stock ...

With markets largely inured to an ever-changing tariff picture, the spotlight turns to Wall Street earnings for clues on how the trade drama is affecting corporate bottom lines. Sign up here ...

BOK Financial (BOKF) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook ...

A full preview of the New York Jets' 2025 defensive tackle group ahead of training camp highlighted by Quinnen Williams.

A latch-less charging handle upgrade for AR-15 rifles, the T-Bone from Strike Industries is an ideal fit for suppressed applications, as it can be configured by the user to redirect gas blowback ...